19
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Influence of FK 506 (Tacrolimus) On Circulating CD4 + T Cells Expressing Cd25 and Cd45ra Antigens in 19 Patients with Chronic Progressive Multiple Sclerosis Participating in an Open Label Drug Safety Trial

, , , , , , , , , , , & show all
Pages 89-98 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Felix Braun & Matthias Behrend. (2006) Basic immunosuppressive drugs outside solid organ transplantation. Expert Opinion on Investigational Drugs 15:3, pages 267-291.
Read now

Articles from other publishers (15)

Yuanyuan Liu, Shuai Chen, Simon Liu, Kevin L. Wallace, Marietta Zille, Jiewen Zhang, Jian Wang & Chao Jiang. (2023) T-cell receptor signaling modulated by the co-receptors: Potential targets for stroke treatment. Pharmacological Research 192, pages 106797.
Crossref
Ahmad J. H. Albaghdadi, Carolyn Ann Feeley & Frederick W. K. Kan. (2019) Low-Dose Tacrolimus Prevents Dysregulated Peri-Conceptional Ovarian and Systemic Immune Cellular Homeostasis in Subjects with PCOS. Scientific Reports 9:1.
Crossref
Laura Northrup, Bradley P. Sullivan, Brittany L. Hartwell, Aaron Garza & Cory Berkland. (2016) Screening Immunomodulators To Skew the Antigen-Specific Autoimmune Response. Molecular Pharmaceutics 14:1, pages 66-80.
Crossref
Dimitrios Karussis. 2017. International Encyclopedia of Public Health. International Encyclopedia of Public Health 145 179 .
Zhengyu Zhu, Wei You, ZhaoHong Xie, Ping Wang, Zhen Liu, Cunfu Wang & JianZhong Bi. (2014) Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis. Journal of International Medical Research 42:2, pages 530-541.
Crossref
Dimitrios Karussis. (2013) Immunotherapy of Multiple Sclerosis. BioDrugs 27:2, pages 113-148.
Crossref
Cuc Davis, Xiaoying Wu, Weimin Li, Hongtao Fan & Manjula Reddy. (2011) Stability of immunophenotypic markers in fixed peripheral blood for extended analysis using flow cytometry. Journal of Immunological Methods 363:2, pages 158-165.
Crossref
Carla G. Hill, Dianna Y. Wu, John Ferbas, Virginia Litwin & Manjula P. Reddy. 2010. Flow Cytometry in Drug Discovery and Development. Flow Cytometry in Drug Discovery and Development 243 266 .
Philipp A. Lang, Doron Merkler, Pauline Funkner, Namir Shaabani, Andreas Meryk, Caroline Krings, Carmen Barthuber, Mike Recher, Wolfgang Brück, Dieter Häussinger, Pamela S. Ohashi & Karl S. Lang. (2010) Oxidized ATP inhibits T-cell-mediated autoimmunity. European Journal of Immunology 40:9, pages 2401-2408.
Crossref
Roger J Mills, Leesien Yap & Carolyn A Young. (2007) Treatment for ataxia in multiple sclerosis. Cochrane Database of Systematic Reviews.
Crossref
Eric M. Yoshida, Virginia A. Devonshire & Alister J.E. Prout. (2014) Remission of Multiple Sclerosis Post-Liver Transplantation. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 31:4, pages 539-541.
Crossref
Bruce G. Gold, Jan Voda, Xiaolin Yu, Gabriel McKeon & Dennis N. Bourdette. (2004) FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: Neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis. Journal of Neuroscience Research 77:3, pages 367-377.
Crossref
Ewa Chelmicka-Schorr, Katherine Wiegmann, Robert Wollmann, Barry G.W. Arnason & Duk Hwan Kim. (1998) Immunoaugmenting Effect of FK 506 on Experimental Allergic Encephalomyelitis in Lewis Rats. Journal of Autoimmunity 11:4, pages 329-334.
Crossref
Khurram Bashir & John N Whitaker. (1998) Current immunotherapy in multiple sclerosis. Immunology and Cell Biology 76:1, pages 55-64.
Crossref
RE Gonsette. (2016) Introductory remarks: immunosuppressive and immunomodulating drugs, where and how do they act?. Multiple Sclerosis Journal 1:6, pages 306-312.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.